Literature DB >> 15986395

Papillary carcinoma of the thyroid <or=1.0 cm: rarely incidental or occult any more.

Andrew A Renshaw1.   

Abstract

BACKGROUND: Papillary carcinomas of the thyroid that measure <or=1.0 cm often are termed incidental or occult tumors. In the current study, the author sought to determine the incidence of such tumors at his institution over a relatively short period.
METHODS: The author reviewed the results from all patients who underwent thyroid resection over a 65-month period and correlated the findings with clinical and cytologic information.
RESULTS: During the study period, a total of 720 resections were performed, and 210 papillary carcinomas were identified that were the reason for the excision. The mean size of these tumors decreased from 2.1 cm to 1.7 cm (P=0.018) over the period of the study, and the percentage of tumors measuring <or=1.0 cm increased from 21% to 39% (P=0.007). The vast majority of these small tumors (73%) were identified by preoperative fine-needle aspiration. During the same period, there were 62 incidental papillary carcinomas, 94% of which measured <or=0.5 cm.
CONCLUSIONS: The size of papillary thyroid carcinomas that were resected at the author's institution decreased significantly, and carcinomas measuring <or=1.0 cm increased significantly. Currently, papillary carcinomas that measure between 0.5 cm and 1.0 cm rarely are either occult or incidental findings in the majority of patients. Copyright (c) 2005 American Cancer Society.

Entities:  

Mesh:

Year:  2005        PMID: 15986395     DOI: 10.1002/cncr.21281

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2007-08       Impact factor: 3.352

2.  BRAF V600E mutation is associated with tumor aggressiveness in papillary thyroid cancer.

Authors:  Su-jin Kim; Kyu Eun Lee; Jun Pyo Myong; Jeong-hwan Park; Yoon Kyung Jeon; Hye Sook Min; So Yeon Park; Kyeong Cheon Jung; Do Hoon Koo; Yeo-Kyu Youn
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

3.  Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.

Authors:  Vivian Y Park; Eun-Kyung Kim; Hye Sun Lee; Hee Jung Moon; Jung Hyun Yoon; Jin Young Kwak
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

4.  Application of the Thyroid Imaging Reporting and Data System in thyroid ultrasonography interpretation by less experienced physicians.

Authors:  Su Yeon Ko; Hye Sun Lee; Eun-Kyung Kim; Jin Young Kwak
Journal:  Ultrasonography       Date:  2013-12-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.